CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: Cynata signs Licence Agreement with TekCyte, page-10

  1. 639 Posts.
    lightbulb Created with Sketch. 156
    LOL, you mean like MSB exhuming a 10 year old trial the other day to announce one day after CYP announced first patient dosed in all-cause ARDS? You know, the trial you are still waiting on Novartis to commit to?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.